https://doi.org/10.1038/sj.bjc.6601883
E
Editta Baldini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
3.7K
Citations
26
h-index
55
i10-index
Editta Baldini is an academic researcher from University of Ferrara. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Treatment and Pharmacology & Lung Cancer Research Studies. The author has an h-index of 26, co-authored 116 publications.
Papers by this author
worksMulticenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety
2004 · British Journal of Cancer · 32 citations
Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study
2012 · BMC Cancer · 15 citations
https://doi.org/10.1186/1471-2407-12-158
EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
2014 · Journal of Experimental & Clinical Cancer Research · 13 citations
https://doi.org/10.1186/s13046-014-0077-6
Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)
2001 · British Journal of Cancer · 10 citations
https://doi.org/10.1054/bjoc.2001.2108
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study
2006 · British Journal of Cancer · 4 citations
https://doi.org/10.1038/sj.bjc.6603074
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat